脱颖而出

HHS Secretary Xavier Becerra Condemns Supreme Court, Unveils Abortion Plan_我的网站

A |     HHS Secretary Xavier Becerra answered questions at a Tuesday press conference following the overturning of Roe v. Wade, the landmark Supreme Court decision that protected the constitutional right to abortion.,"Friday's Supreme Court decision was despicable. But it was not unpredictable. HHS has been preparing for this for some time," he began.,“FDA has found medication abortion treatments like mifepristone safe and effective,” said Becerra, who preempted his answer to press questions by saying that he would answer well enough while “stay[ing] in the legal confines.”,Women Hoarding Birth Control, Abortion Pills After Roe v Wade Overturned, Media SaysYesterday, 18:18 GMT,“Those medications that may be classified as medication abortion that the FDA has approved as safe and effective are therefore available for prescription,” explained Becerra, before adding that he can’t say what precisely “that means” because the HHS is trying to stay within the “confines of the law.”,“Even though it’s a law that I personally believe jeopardizes the health of women, we will stay within the confines of the law,” said Becerra.,As for the legal conditions under which the abortion pill can be prescribed, Becerra’s cautious response to reporters and Americans was to “stay tuned.”,Becerra did provide some hope on the issue of abortion care for pro-choice advocates and women’s health care providers like Planned Parenthood, which says exclusion from state family planning programs violates federal law. He explained that if a state is using federal funding for healthcare programs, they must respect laws at the federal level even when those services provide abortion care.,VP Kamala Harris Did Not Believe Justices When They Said Roe Was SettledYesterday, 23:31 GMT,Becerra added that the White House isn’t interested in “going rogue” and providing Americans with abortion services.,"We're not interested in going rogue and doing things just because we want to make sure what we tell Americans is accurate—because we hear, we know, a lot Americans are hearing a lot of inaccurate information," Becerra replied after ABC’s Mary Bruce asked him why the White House’s proposals weren’t more prepared for the fall of Roe v. Wade if they had been expecting it.,"And so to every American who's impacted: My apologies that, as I said, we can't tell you there's a silver bullet. But what I am saying to you is that the more we dig, we will do everything we can with what we find to make sure we're protecting women's reproductive health care services. It takes a little time because we want to do it right, and we want to do it according to the law.",On Friday, Attorney General Merrick Garland announced that “states may not ban” abortion pills that are approved by the FDA. However, he failed to explain how the FDA could ensure access to abortion pills such as mifepristone.。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

Current article:http://www.liawucunsainantaonao.sbs/news/20260826_39478.htm

Published on:15:32:52